CLIA Regulations Assessment Workgroup

The CLIA Regulations Assessment Workgroup provides input to CLIAC for deliberation on how the CLIA  might specifically be updated, considering the April 2019 reports by the Personnel Regulations, Non-Traditional Workflow Models, and NGS workgroups. The workgroup is charged with providing advice to CLIAC for consideration in making recommendations to HHS on revising the CLIA regulations. 


Kimberle C. Chapin, MD
Medical and Scientific Affairs

Gregory N. Sossaman, MD
System Chairman, Ochsner Health System
Department of Pathology and Laboratory Medicine
Ochsner Medical Center


Workgroup Designated Federal Officer and Ex Officio Members 


Designated Federal Officer
Heather L. Stang, MS, MLS
Senior Advisor for Clinical Laboratories
Clinical Laboratory Improvement Advisory Committee Executive Secretary
Division of Laboratory Systems 
Office of Laboratory Science and Safety 
Centers for Disease Control and Prevention 

Ex Officio Members
Sarah Bennett, MT(ASCP) 
Technical Director 
Division of Clinical Laboratory Improvement and Quality 
Quality, Safety and Oversight Group 
Centers for Clinical Standards and Quality 
Centers for Medicare & Medicaid Services 

Víctor R. De Jesús, PhD 
Chief, Quality and Safety Systems Branch
Division of Laboratory Systems
Office of Laboratory Science and Safety
Centers for Disease Control and Prevention 

Tamara Pinkney, MT(ASCP) 
CLIA Program Lead/Policy Analyst 
Division of Program Operations and Management 
Office of In Vitro Diagnostics  
Center for Devices and Radiological Health 
Food and Drug Administration